Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
4641 studies found for:    "Depressive Disorder" [DISEASE]
Show Display Options
Rank Status Study
21 Terminated Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder
Condition: Depressive Disorder, Major
Interventions: Drug: CP-316,311;   Drug: Placebo;   Drug: Sertraline
22 Completed
Has Results
Phase 1 Study to Assess the Safety/Tolerability of Brexpiprazole as Adjunctive Therapy in Elderly Subjects With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Brexpiprazole;   Drug: Placebo
23 Completed
Has Results
A Study to Assess the Efficacy and Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder.
Condition: Major Depressive Disorder
Interventions: Drug: TC-5214;   Drug: Placebo
24 Completed Efficacy, Safety and Tolerability of Agomelatine in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: agomelatine;   Drug: placebo
25 Completed
Has Results
Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: OPC-34712;   Drug: Placebo;   Drug: ADT
26 Completed Efficacy, Safety and Tolerability of Agomelatine in the Prevention of Relapse of Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: agomelatine;   Drug: placebo
27 Completed Exploring a Potential Blood Test to Diagnose Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention:
28 Completed An Eight-week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder
Condition: Depressive Disorder
Interventions: Drug: saredutant (SR48968);   Drug: placebo;   Drug: escitalopram
29 Unknown  The Metabolic Effects of Antidepressants in Patients Diagnosed With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention:
30 Completed Safety and Pharmacodynamic Study of ABT-436 in Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: ABT-436;   Drug: Matching Placebo
31 Completed Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: DVS-233 SR
32 Completed A Placebo- and Paroxetine-controlled Study of the Efficacy, Safety and Tolerability of Agomelatine (25 or 50 mg) in the Treatment of Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: Agomelatine;   Drug: paroxetine;   Drug: placebo
33 Completed
Has Results
A Study of Aripiprazole in Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Aripiprazole+ ADT;   Drug: Placebo+ ADT
34 Completed Study of Escitalopram in Adult Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
35 Completed
Has Results
Escitalopram in Adult Patients With Major Depressive Disorder
Condition: Major Depressive Disorder
Interventions: Drug: Escitalopram;   Drug: Placebo
36 Completed Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder
Condition: Major Depressive Disorders
Intervention: Drug: amibegron (SR58611A)
37 Completed AZD6765 Severe Major Depressive Disorder (MDD) IV
Condition: Major Depressive Disorder
Interventions: Drug: AZD6765;   Drug: Placebo
38 Completed Testing the Effectiveness of a Computer-based Program for Depression
Condition: Major Depressive Disorder
Interventions: Behavioral: Active computer-based training;   Behavioral: Inert computer training
39 Completed
Has Results
Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine
40 Completed
Has Results
Efficacy and Safety Study of a Combination Product [Drug:BCI-024 (Buspirone) and Drug:BCI-049 (Melatonin)] to Treat Major Depressive Disorder (MDD)
Condition: Major Depressive Disorder
Interventions: Drug: BCI-024: over-encapsulated Buspirone tablet 15 mg QD and BCI-049: over-encapsulated Melatonin tablet 3 mg QD;   Drug: BCI-024 (Buspirone);   Drug: Matching placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.